Lv4
418 积分 2024-06-14 加入
Primary Aldosteronism Medical Treatment Outcomes (PAMO) Beyond 12 Months
2天前
已完结
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
7天前
已完结
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
7天前
已完结
Beta-1 receptor mediation of renin secretion elicited by low-frequency renal nerve stimulation
7天前
已完结
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
8天前
已完结
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial
8天前
已完结
Neural Control of Renal Function
10天前
已完结
Splanchnicectomy for essential hypertension; results in 1,266 cases
10天前
已完结
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial
17天前
已完结
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
21天前
已完结
皖公网安备34019202002308
